Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 19 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Identifying existing health care services that do not provide value for moneyElshaug, A.; Moss, J.; Littlejohns, P.; Karnon, J.; Merlin, T.; Hiller, J.
2001Cost analysis of a hospital-at-home initiative using discrete event simulationCampbell, H.; Karnon, J.; Dowie, R.
2008Modelling the expected net benefits of interventions to reduce the burden of medication errorsKarnon, J.; McIntosh, A.; Dean, J.; Bath, P.; Hutchinson, A.; Oakley, J.; Thomas, N.; Pratt, P.; Freeman-Parry, L.; Karsh, B.; Gandhi, T.; Tappenden, P.
2001Economic evaluation alongside n-of-1 trials: getting closer to the marginKarnon, J.; Qizilbash, N.
2009Informing disinvestment through cost-effectiveness modelling: is lack of data a surmountable barrier?Karnon, J.; Carlton, J.; Czoski-Murray, C.; Smith, K.
2008A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degenerationKarnon, J.; Czoski-Murray, C.; Smith, K.; Brand, C.; Chakravarthy, U.; Davis, S.; Bansback, N.; Beverley, C.; Bird, A.; Harding, S.; Chisholm, I.; Yang, Y.
2003Performance treatment pathways and effects of alternative policy options for screening for developmental dysplasia of the hip in the United KingdomDezateux, C.; Brown, J.; Arthur, R.; Karnon, J.; Parnaby, A.
2007A review and critique of modelling in prioritising and designing screening programmesKarnon, J.; Goyder, E.; Tappenden, P.; McPhie, S.; Towers, I.; Brazier, J.; Madan, J.
2006Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancerDelea, T.; Karnon, J.; Smith, R.; Johnston, S.; Brandman, J.; Sung, J.; Goss, P.
2003The role of modelling in prioritising and planning clinical trialsChilcott, J.; Brennan, A.; Booth, A.; Karnon, J.; Tappenden, P.